Conning Inc. Grows Stake in Danaher Corporation $DHR

Conning Inc. raised its stake in Danaher Corporation (NYSE:DHR) by 10.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 23,581 shares of the conglomerate’s stock after acquiring an additional 2,181 shares during the period. Conning Inc.’s holdings in Danaher were worth $4,658,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the business. Hills Bank & Trust Co boosted its position in shares of Danaher by 0.3% during the first quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate’s stock valued at $3,693,000 after buying an additional 53 shares during the last quarter. Worth Financial Advisory Group LLC boosted its position in shares of Danaher by 4.6% during the second quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock valued at $236,000 after buying an additional 53 shares during the last quarter. Sageworth Trust Co boosted its position in shares of Danaher by 2.3% during the first quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate’s stock valued at $493,000 after buying an additional 54 shares during the last quarter. 1834 Investment Advisors Co. boosted its position in shares of Danaher by 3.3% during the first quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate’s stock valued at $342,000 after buying an additional 54 shares during the last quarter. Finally, Bruce G. Allen Investments LLC boosted its position in shares of Danaher by 13.1% during the second quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate’s stock valued at $92,000 after buying an additional 54 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Down 1.0%

NYSE DHR opened at $202.53 on Friday. The stock’s 50-day moving average price is $200.66 and its 200-day moving average price is $197.25. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $279.41. The company has a market capitalization of $145.02 billion, a P/E ratio of 43.09, a price-to-earnings-growth ratio of 2.91 and a beta of 0.77.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter last year, the company earned $1.72 earnings per share. The business’s revenue for the quarter was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.32 dividend. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is 27.23%.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the transaction, the director owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 11.10% of the stock is owned by company insiders.

Analysts Set New Price Targets

DHR has been the topic of several recent analyst reports. Robert W. Baird increased their price objective on Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a research report on Friday, July 18th. Bank of America lowered their target price on Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a report on Monday, September 22nd. Rothschild & Co Redburn reissued a “neutral” rating and issued a $220.00 target price (down previously from $245.00) on shares of Danaher in a report on Wednesday. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a report on Friday, June 27th. Finally, Royal Bank Of Canada set a $241.00 target price on Danaher in a report on Tuesday, September 2nd. Seventeen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $244.60.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.